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Abstract
Introduction: Non-Alcoholic fatty liver disease (NAFLD) is the most common chronic liver
condition in the U.S and is an emerging public health concern in adolescents. Risk factors for
adolescent NAFLD remain largely unexamined.
Aim: To investigate if demographic and dietary-related factors are linked with NAFLD in
adolescents.
Methods: Cross-sectional data from NHANES (2001-2006) ages 12-19 (n=4714) were analyzed.
NAFLD was defined as >30 u/L ALT. Food Insecurity levels (child, adult, household),
race/ethnicity, sex, BMI, and the Dietary Inflammatory Index (DII) were tested using
multivariate binary logistic regression with elevated ALT (no, yes) as the dependent variable.
Results: Risk for elevated ALT among Non-Hispanic Blacks was 1.25 times greater compared to
Non-Hispanic Whites (95% CI 1.00-1.57). Higher DII quartiles (i.e., increasingly proinflammatory) show a possible link with elevated ALT (e.g., Q2vsQ1: OR=1.23, 95% CI .951.59; Q3vsQ1: OR=1.31, 95% CI 1.01-1.69; Q4vsQ1: OR=1.14 95% CI .88-1.48). Findings
regarding food security were inconclusive.
Conclusion: This study is the first report, to our knowledge, that Non-Hispanic Blacks might be
at greater risk for adolescent NAFLD compared to Non-Hispanic Whites. Lack of an association
with Hispanics is inconsistent with prior research in adults, however. Future research is
suggested to understand underlying risk factors linked with disparate risk. A potential association
with a pro-inflammatory diet also warrants further study. We posit that inconclusive results about
food insecurity might due to lower rates of obesity, a known risk factor for NAFLD, in this
vulnerable population.
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Introduction
Overview. Non-Alcoholic Fatty Liver disease (NAFLD) is a chronic liver condition caused by
excess accumulation of fat in the liver. NAFLD is the most common chronic liver disease in
children and adults in industrialized countries and is associated with an increased risk of
cardiovascular disease, type 2 diabetes (T2D), and liver-related morbidity (Alkhouri & Kay,
2012). NAFLD can be divided into 2 subtypes: 1) Simple fatty liver disease, which is
characterized by no inflammation or cell damage; and 2) Non-alcoholic steatohepatitis (NASH)
where inflammation and cell damage do occur. The difficulty with NAFLD and NASH is the
lack of identifiable symptoms, so they are considered silent diseases. While the direct cause of
NAFLD is not known, it has been reported that prevalence increases with the occurrence of
obesity, T2D, insulin resistance, and high lipid disorders. Pediatric NAFLD is thought to affect
around 1 in 10 children in the United States and 34% of children with obesity (Draijer et al.,
2019). More research needed is to determine the lifestyle risk factors, improvements in screening
methods, and potential treatment therapies. An unexplored potential risk factor is the association
with food insecurity as a predictor for pediatric NAFLD due to its relationship with poor diet and
obesity, which is what forms the research question of this thesis. Other variables that have been
found to be potential factors such as race/ethnicity, c-reactive protein (CRP), the dietary
inflammatory index (DII), body mass index (BMI) we examined for the cohort.

Health Outcomes. NAFLD is characterized with metabolic syndrome (MetS) along with other
entities such as diabetes, being overweight, high cholesterol, and high blood pressure (Kumar,
Priyadarshi, & Anand, 2020). The two subtypes, nonalcoholic fatty liver (NAFL) and NASH are
differentiated by the occurrence of inflammation or cell damage. The gold standard for NAFLD
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diagnosis is through histology of the liver tissues, most recently utilizing the NAFLD activity
score developed by the Pathology Committee of the NASH Clinical Research Network. The
score is used to determine the amount of fat accumulation, inflammation, and fibrosis
(Lindenmeyer & McCullough, 2018). To accurately diagnose NAFLD, all other potential causes
of liver steatosis such as alcohol consumption, hemochromatosis, viral hepatitis, and certain
hereditary disorders must be excluded (Chalasani, 2012). It is important to make a histological
distinction between the subtypes because therapeutic interventions for treatment vary for each,
and as the disease progress, those afflicted have increased risk of fibrosis, cirrhosis and end-stage
liver disease (Lindenmeyer & McCullough, 2018). The spectrum of diagnosis ranges from
simple steatosis (SS), to NASH, and then ultimately hepatocellular carcinoma (HCC). This
progression is still incompletely defined as SS is now shown to be more progressive than
originally believed. Along with the variants associates with MetS, some genetic polymorphisms
have a significant impact on the progression (Kumar et al., 2020).
There have been many studies looking into the progression of NAFL versus NASH to
better understand the connection between them. A 2006 study by Ekstedt found that NASH is
associated with a reduced survival more than NAFL and death being most commonly cause by
cardiovascular disease. This study also found that elevated liver enzymes such as Alanine
Aminotransferase (ALT) and Aspartate Aminotransferase (AST) is a risk factor for developing
end-stage liver disease (Ekstedt, 2006). Initially it was thought that NAFL could not progress to
NASH, but a 2013 study found that, especially in the presence of risk factors, patients with
NAFL could progress to NASH with fibrosis. Those with any degree of mild inflammation or
fibrosis were at higher risk for progression than those with only liver fat build-up. Progression
occurred in tandem with elevated ALT, higher weight gain, and higher diabetes incidence (Pais
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et al., 2013). The final stage of NAFLD, HCC, is the most common type of primary liver cancer
and is the fastest-rising cause of cancer-related deaths in the US. HCC occurs most often in those
with chronic hepatitis C (HCV), hepatitis B (HBV), NAFLD, diabetes, or heavy alcohol drinkers.
The incidence of HCC has been increasing in North America but decreasing in Japan and parts of
China, which were traditionally high-risk regions (Kulik & El-Serag, 2019). A 2015 study by
Kallwitz et al., found that this trend is likely due to higher rates of HCV, HBV, and NAFLD and
that Hispanic Americans with HCV or NAFLD have a higher risk of progression to cirrhosis and
HCC (Kallwitz et al., 2015).
NAFLD has long been considered a display of MetS in the liver. Diagnosis of MetS
requires confirmation of 3 of the 5 following factors: obesity, hypertension, low HDL
cholesterol, hypertriglyceridemia, and fasting hyperglycemia. Determination is made based on
waist circumference over 102 cm for males and 88 for females, blood pressure over 135/85,
fasting blood glucose over 100 mg/dl, HDL under 40 mg/dl in males and under 50 mg/dl in
females, and triglycerides over 150 mg/dl (Sumner & Cowie, 2008). NADLF has been found to
present clinical and laboratory data like that of diabetes and obesity, including insulin resistance,
increased triglycerides, increased uric acid, and low HDL cholesterol (Marchesini et al., 2001).
In 2003, Marchesini et al. documented that MetS was a high risk for NASH and that increasing
prevalence of obesity and diabetes in the population would lead to a large risk of liver failure in
the coming decades which is what has occurred (Marchesini et al. 2003). Many studies have
strongly associated ALT with NAFLD and NAFLD is the common cause of unexplained mild
ALT elevation (Liu, Que, Xu, & Peng, 2014). Liu et al. suggest that when elevated ALT is
present without viral hepatitis or excessive alcohol consumption, NAFLD is the cause.
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Currently, NAFLD is known to be a risk factor with many diseases such as type 2
diabetes mellitus (T2DM), cardiovascular disease (CVD), chronic kidney disease (CKD),
polycystic ovarian syndrome, obstructive sleep apnea, psoriasis, osteoporosis, stroke, acute
pancreatitis, and recently with sarcopenia (Kumar et al., 2020). NAFLD has also become the
second most common indication for liver transplantation (LT) after chronic hepatitis C, with new
LT waitlist registrants increasing by 170% from 2004-2013 (Lindenmeyer & McCullough,
2018). NAFLD is both a cause in the development of T2DM, but also a consequence of preexisting T2DM. Two large meta-analyses confirmed this relationship, with 58% of NAFLD
patients developing T2DM (Kumar et al., 2020; Musso, Gambino, Cassader, & Pagano, 2011).
The risk of T2DM was found to be three times higher for patients with NASH versus SS and
showed increased risk of NAFLD progression to NASH and HCC. Overall, the coexistence of
diabetes and NAFLD in a patient increases risk of progression and complications related to both
diseases. Increased risk of CVD has consistently been seen with studies showing increased
carotid artery thickness, increased arterial stiffness, impaired flow of dilated blood vessels, and
endothelial dysfunction ((Kumar et al., 2020). A 2016 study found that progression of NAFLD is
associated with increased risk of subclinical carotid atherosclerosis (Sinn et al., 2016). Studies
confirm the association of increase CVD prevalence, but more research is needed to determine
the association of increased CVD mortality and if these associations are due to shared risk
factors or NAFLD itself is and additional risk for CVD (Kumar et al., 2020). A 2014 metaanalysis on 64,000 subjects found NAFLD was associated with a 2-fold increase in incident and
prevalent CKD, with more progressive forms such as NAFL with fibrosis and NASH being more
positively correlated with CKD in comparison to SS (Musso et al., 2014). The associations
recognized in the review by Kumar et al. along with those by Lindenmeyer & McCullough
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document the increasing risk and associations of NAFLD, with projections showing an everincreasing global impact.
Treatment of NAFLD includes working to treat the liver disease along with lifestyle
modifications to help with the associated risk factors of diabetes, obesity, and hyperlipidemia.
Chalasani et al. found that weight loss can reduce fat in the liver, inflammation and scarring and
most clinicians are recommended to get patients to lose weight through healthy food choices and
increase physical activity (Chalasani, 2012). Losing 3-5% of body weight can reduce fat in the
liver and it was found that a low-calorie diet along with increased physical activity can improve
NAFLD and NASH outcomes (Ahmed, Wong, & Harrison, 2015). It has also been seen that
exercise alone, without weight loss, can improve NAFLD outcomes, with a combination of
exercise, medication, and diet changes being the most effective (Oliviera, de Lima Sanches, de
Abreu-Silva, & Marcadenti, 2016). Weight reduction through bariatric surgery has shown
benefits for NAFLD patients as well. A medication considered for treatment is metformin which
is commonly prescribed for diabetic patients but studies on the effectiveness of metformin for
NAFLD have shown mixed results (Sao & Aronow, 2018). Generally, there is no standard
pharmacological treatment, with the standard options being to target weight loss through diet
changes and physical activity. This is most applicable for those with NASH as it has been found
that a loss of >7% body fast is associated with disease regression. The main difficulty in
treatment is implementing the lifestyle changes in clinical care and the daily life of the patient
(Romero-Gomez, Zelber-Sagi & Trenell, 2017). With more big data analyses being conducted on
this topic, the true global disease burden can be seen with the increase in progression, associated
conditions, and need for enhanced treatment and prevention options.
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Epidemiology. The spread of NAFLD can be seen worldwide but the exact incidence and
prevalence are unknown due to the lack of accuracy in the noninvasive markers related to the
condition. Liver biopsy for histology is invasive and expensive so noninvasive measures such as
liver-associated tests, imaging, or spectroscopy methods have been considered (Ong, & Zobair,
2007). Community surveys have utilized ultrasonography or proton NMR spectroscopy whereas
studies based on elevated liver enzymes were found to systematically underestimated the true
prevalence. Overall, global prevalence of NAFLD is currently estimated to be 24% as of 2018
(Younossi et al., 2018). Through data from the National Health and Nutrition Examination
Surveys (NHANES) from 1988 to 2008, it has been seen that NAFLD prevalence has doubled in
the US from 46.8% to 75.1% of chronic liver disease cases. It is projected that this will increase
by 21% by 2030, leading to an overall prevalence of 33.5% in the general population (Kumar et
al., 2020).
Globally, the highest rates are from South America (31%), the Middle East (32%), Asia
(27%), the USA (24%), and Europe (23%). The least common incidence is reported in Africa
with 14%. A 2016 meta-analysis conducted by Younossi et al. determined NAFLD prevalence in
the USA through ultrasonography, Fatty Liver Index (FLI), and the International Classification
of Diseases (ICD). The findings followed that disease diagnosis solely based on ICD or blood
testing led to underreporting. This study found that prevalence varied by ethnicity, with Hispanic
American having the highest rates, followed by Americans of European descent and African
Americans. While unconfirmed, this disparity is thought to be due to socioeconomic disparities,
along with the possibility of genetic factors and presence of MetS. This finding is supported
through many previous studies but contradicts the findings of higher obesity and hypertension in
African American patients and Serif et al., found that there is a concern that the disease burden
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of NAFLD on the African American population is actually underestimated (Sherif et al., 2016).
Another assessment of NHANES data found that NAFLD posed a significantly higher risk in
black adolescents but for adults, education was inversely related (Jaradat, 2017). A 2017 study
found NAFLD prevalence in the US as 30% with 10.3% of these cases having advanced fibrosis.
This study defined NAFLD as subjects having a US Fatty Liver Index (USFLI) greater than 30
which has been shown to correlate with NAFLD diagnosed through ultrasound. It was found that
subject with NAFLD were more likely to have higher ALT and AST (Le et al., 2017).
NAFLD without the presence of obesity is termed “lean NAFLD”. This was initially
described in Asian populations and believed to be more benign than NAFLD, but studies have
found that patients with lean NAFLD have impaired insulin sensitivity, increased cardiovascular
risk, and increased liver fat levels. A study by Fracanzani et al. in 2011 found that 55% of
patients without obesity did have NASH and fibrosis and a study by Leung et al. in 2017 found
that 51.9% of obese versus 43.5% of non-obese patients had NASH suggesting that obesity
might not be as associated with fibrosis progression. Since it is harder to diagnose and identify
risk factors for those with lean NAFLD, further research is needed into the topic (Younossi et al.,
2018).

Pediatric NAFLD. Pediatric NAFLD is defined as chronic hepatic steatosis in children when no
occurring with genetic/metabolic disorders, infections, alcohol consumption or malnutrition. In
most children, NAFLD is associated with insulin resistance, obesity, high triglycerides, and low
HDL cholesterol levels (Vos et al., 2017). As obesity in children increased worldwide, so has the
prevalence rates of pediatric NAFLD. In the general pediatric population NAFLD presents at
7.6% while in the obese pediatric population it is 34.2% (Anderson et al., 2015). It has been seen
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that 66% of children with biopsy proven NAFLD had one or more metabolic risk factors, with
T2DM and insulin resistance having the strongest link (Draijer et al., 2019). Children with
NAFLD are at high risk of progressing to end-stage liver disease and cases of liver
transplantation (Alkhouri et al., 2016) While this public health problem is severely increasing,
there is a large lack of research in the area of pediatric NAFLD and many unknowns.
From a special report by Hatton et al. (2018): “Pediatric NAFLD has previously been
ascribed to three broad histological types: (1) Centrilobular steatosis, ballooning degeneration
and inflammation with perisinusoidal fibrosis; (2) periportal inflammation and steatosis with
portal fibrosis; and (3) overlap between 1 and 2.” (p. 961). Type 2 is more common in children
than adult NASH but there is little known on why or how NASH is different between the
populations. It is unknown how to stratify children into risk groups for interventions based on
related diseases such as CVD and diabetes and it is thought that pediatric NASH has a different
immune process than adult NASH, but it is not well understood. The direct cause of pediatric
versus adult NAFLD is different and further research is needed to determine appropriate
diagnosis methods and treatment. It has been found that prenatal and postnatal factors contribute
to the development of pediatric NAFLD, but the etiology and pathophysiology are not well
defined (Hatton et al., 2018). A 2013 study found support for the racial/ethnic differences in the
link between MetS and NAFLD in adolescent populations. It found that the prevalence of MetS
in was 10.6% in Hispanics, 8.4% in Whites and 4.2% in Blacks and this was paralleled with
13.7% in Hispanics, 8.6% in Whites and 5.2% in blacks for elevated ALT. ALT was defined as
the best marker for NAFLD as an alternative to biopsy as ALT had a .92 sensitivity to
identifying fatty-fibrotic findings on ultrasound. This study also found that adolescents with
MetS with 7.8 times more likely to have elevated ALT (DeBoer et al., 2013). The use of ALT as
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a marker for pediatric NAFLD has been supported by the North American Society for Pediatric
Gastroenterology, Hepatology & Nutrition in a clinical practice guideline released in 2017. The
ALT assay has been standardized across facilities but the cut-off points for normal ALT levels
has not. In the US, the cut-off has been defined as 22 mg/dl for girls and 26 mg/dl for boys while
in Canada, the upper limit for normal ALT was 30 mg/dl for children 1-12 years old and 24
mg/dl for children 13-19 years old. NASH was found to be associated with ALT greater than 8U/L (Vos et al., 2017).
Children with NAFLD and fibrosis are at higher risk of long-term liver complications due
to their life span and as diagnosis is difficult without biopsy and treatment is limited to lifestyle
interventions, the pediatric NAFLD population is at very high risk for complications. The ideal
solution is obesity prevention early on, further research into this specific population, and
increased awareness about this growing public health issue (Draijer et al, 2019). The pediatric
obesity rate has risen from 5% to 16.9% from 1960 to 2010 and since weight gain during
childhood carries a higher risk of NAFLD than weight gain in adulthood, risk of progressive
NAFLD such as fibrosis, cirrhosis, HCC, end-stage liver disease, and liver-related death are
increased (Younossi et al., 2018).
Even though pediatric NAFLD has such high prevalence and poor outcomes, it remains
under-studied and under-recognized, allowing this trend to continue to increase for the
foreseeable future. There are unmet needs in the areas of screening, diagnosis, treatment, and
awareness. For those whom on the extreme end of the obesity spectrum, there are no nonsurgical options and there is a lack of collaboration between clinical specialties and targeted
therapeutic interventions that could improve patient outcomes (Temple et al., 2016). More
research is needed to find novel biomarkers and therapeutic agents to avoid the current risk of
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long-term morbidity. The pediatric population is more vulnerable to genetic and environment
factors so further research is also needed into the perinatal and postnatal stressors that increase
risk of NAFLD onset (Goldner & Lavine, 2020). Dietary factors have been found to be
associated with pediatric NAFLD and a study conducted in Korea found that children with
suspected NAFLD were found to have elevated urinary sodium levels and elevated cholesterol
intake (Kim & Lee, 2020). This is an area for further research to be able to best determine
preventive dietary measures. In Dutch hospitals a survey was conducted to determine pediatric
NAFLD screening practices and found that while widely performed, there is no uniform protocol
to follow (Draijer et al., 2020). Overall, despite the high prevalence and serious complications,
pediatric NAFLD is not as widely researched as adult onset NAFLD and leaves room for further
exploration.

Food Insecurity. As defined by the US Department of Agriculture (USDA), food security (FS)
is defined as a household always having access to enough food for all members of the household
to lead an active, healthy lifestyle. Food insecurity is defined as households that were uncertain
of having or being unable to get enough food at times due to lack of money or other resources.
Low food security is defined as households getting enough food to avoid substantially disrupting
eating patterns or food intake by use of coping strategies such as a less varied diet, a food
assistance program, or emergency food from a food pantry. Very low food security is defined as
households that had a disruption of normal eating patterns for one or more member of the house
along with reduced food intake due to lack of money or other resources. In 2018, 11.1% of
households were food insecure, 6.8% were low food security and 4.3% were very low food
security at some time during the year. These values are all lower than the food insecurity figures
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for 2017 (Coleman-Jensen et al., 2019). Food insecurity affects 35% of low-income US
households and has been associated with increased risk of diabetes, hypertension, obesity, and
CVD (Golovaty et al., 2020). While these conditions have been shown to be strongly linked to
NAFLD, there has been only one study looking into the correlation of food insecurity and
NAFLD risk. The 2020 study by Golovaty et al. examined food insecurity as an independent risk
factor for NAFLD in low-income adults. It was found that 29% of adults were food insecure and
that food insecure adults were more likely to have NAFLD and advanced fibrosis than adults
who were food secure (Golovaty et al., 2020). This is a huge area of potential research to further
our understanding of the risk factors associated with NAFLD and improve upon
recommendations for intervention and treatment.

Systems Thinking. NAFLD is the most common form of chronic liver disease and is likely to
become the leading cause of liver failure and liver transplantations in the pediatric populations.
This disease is widespread and highly interconnected with other MetS disorders such as obesity,
diabetes, and CVD. The main issue in the area of pediatric NAFLD is the lack of research.
Currently, the main treatment option is weight loss through diet and exercise. If more research is
conducted into the etiology and pathophysiology, the is potential for alternative diagnostic tests,
more interventions, better treatment options, and more awareness about the associated
conditions. The increase in pediatric cases is tied to the increase in obesity worldwide. The
obesity epidemic is due to the current food habits and food available to people around the world.
If people are more food secure (having access to fresh, health, inexpensive options regularly),
then there is no need to purchase fast food or other unhealthy options. This is impacted by the
socioeconomic levels of families, the local environment they live in and access to care, and
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knowledge on how to be and stay healthy. For children, funding and implementation of the
national school breakfast, lunch, summer programs could heavily impact food security.
Government policy based on the findings of the scientific community regarding food security,
food deserts, obesity, NAFLD, and risk factors could drastically change the obesity epidemic. If
policy could be enacted for better regulations on fast food companies and increasing the number
of supermarkets with fresh food in areas that need it. For people who need assistance, policy
impacts the availability of Supplemental Nutrition Assistance Program (SNAP), formerly known
as food stamps, and stipends. Policy can also impact the funding that goes into research and the
funding that goes into other stakeholders such as hospitals, physicians, local health departments,
and insurance companies. NAFLD has many comorbidities which impact these stakeholders
when treatment is needed for NAFLD, CVD, and diabetes. With the increase in association for
liver transplantation, hospitals, physicians, insurance companies, and the overall cost on the
healthcare system increases. If the initial risk factors can be intervened upon, then all the
following procedures and costs could be avoided.
The public health issue of rising pediatric NAFLD is not a simple problem to treat with a
one-step solution, but a complex issue that ties into many stakeholders in the healthcare system.
By increasing awareness on the large impact of the disease, it is more likely that particular
research will be conducted in the unmet areas, better policy can be enforced to improve structural
and environmental issues, and a more holistic approach can be taken to try and reduce the global
burden of this disease.
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Prevention, Diagnosis, and Treatment of Emerging Incidence of NAFLD in Adolescents

Figure 1. Systems Thinking Map
13

Statement of the Problem. There is very little understanding of why certain people get NAFLD
and why in some people this condition is exacerbated to levels of extreme cirrhosis. There is also
very little known about the symptoms of NAFLD, making it very difficult to identify at-risk
populations. NAFLD has become increasingly prevalent in the pediatric population. Previous
thesis work identified that NAFLD is more prominent in black adolescents and in adults with
less than a college degree (Jaradat, 2017). This thesis also found that the three-fold greater
prevalence of elevated uric acid in both age groups, which warrants further research and might
have translational value for screening for liver disease. By adding the risk factor of food
insecurity into this study, there is a likelihood to more deeply understand a possible underlying
factor associated with a racial difference.
Rates of pediatric NAFLD are currently following the rising rates in childhood obesity,
which is a well-established public health problem. Many studies have found that food insecurity
is tied to obesity. If food insecurity is identified as a social determinant of NAFLD, the findings
could add to the growing evidence about the harms of food insecurity and shape future public
policies to increase awareness and promote improvements, especially in highly impacted
populations. If correlations are found, then there is a high possibility that structural bias, social
inequities, and racism could be tied to the food insecurity predictors and systems thinking will
need to be applied to the findings to understand the interactions of these aspects, and how we can
use these findings to potentially reduce prevalence of pediatric NAFLD. As a disease of serious
long-term consequences, new causative information about NAFLD is important, especially given
the lack of studies present on pediatric NAFLD.
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Methods
Sample. All data analysis was conducted using the continuous 2001-2006 NHANES data set.
NHANES is a population-based surveillance program conducted by the National Center for
Health Statistics (NCHC) that has been continuously conducted since 1999. (Please note: Dr.
Swede has received blanket approval from the UCH IRB for use of NHANES datasets under
Exempt Status, i.e., non-human subjects research, for use in student and faculty research
projects.) The survey includes a questionnaire, an interview, an at-home medical examination,
and a mobile center for laboratory tests. The data includes a variety of variables related to
physical and environmental conditions that tie to prevalent health conditions in the U.S. For this
analysis, participants were included if they were 12-19 years old (n=7078) and had the NAFLD
indicator marker (ALT) documented. Pregnant females were excluded per previously conducted
studies examining ALT and NAFLD (Umehara, 2018). The study sample (n=4714) consists of
males (n=2412) and non-pregnant females (n=2302) with valid ALT results, n=3921 for normal
ALT and n=793 for elevated ALT.
Variables. In the existing dataset, NAFLD was defined by two established blood markers, ALT
and AST. Per the NASPGHAN clinical practice guidelines, ALT is the recommended standard
marker for NAFLD (Vos et al., 2017). In this study, normal ALT was defined as lower to equal
to 30 U/L and elevated ALT was defined as greater than 30 U/L. As the NASPGHAN guidelines
had discrepancies for US versus Canadian recommendations, we followed thresholds as
described in DeBoer et al. (2013). Several independent variables were examined in this study to
ensure no selection bias along with no sample bias as evident in Table 2. Demographic
characteristics examined were sex and race/ethnicity. Education could not be examined due to
lack of data in the selected study cohort.
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C-reactive protein (CRP) is an inflammatory marker and has been linked to CVD and
obesity (Barinas-Mitchell et al., 2001). The original CRP data was sorted as low risk if <1 mg/L,
average risk between 1 and 3 and high risk above 3 mg/L. CRP value >10 mg/L were excluded
as it is indicative of an acute infection. This data was transformed into quartiles of <.09 (Q1),
.09-.23 (Q2), .23-.53 (Q3) and >.52 (Q4) to allow for better population distribution analysis.
BMI was categorized as underweight (<18.5), normal (18.5-24.9), overweight (25.0-29.9), obese
(30.0-34.9) and morbidly obese (>35) per CDC guidelines.
Dietary inflammatory Index (DII) is based on 8 pro-inflammatory and 8 antiinflammatory components to assess the inflammatory potential of dietary factors (Kanauchi et
al., 2019). DII was developed to provide a quantitative means for assessing the role of diet in
relation to health outcomes designed to be applicable across all human studies with
adequate dietary assessment. DII is a continuous variable which was transformed into quartiles
for population comparison analysis with the 1st to 4th quartile going from less to more
proinflammatory (Hébert et al., 2019).
NHANES has created summary variables that characterize food insecurity using U.S.
Household Food Security Survey Module split into household, adult, and child:
Household: whether the statement was often true, sometimes true, or never true for (you/your
household) in the last 12 months
1)
“(I/We) worried whether (my/our) food would run out before (I/we) got money to
buy more.” Was that often true, sometimes true, or never true for (you/your household) in
the last 12 months?
2)
“The food that (I/we) bought just didn’t last, and (I/we) didn’t have money to get
more.” Was that often, sometimes, or never true for (you/your household) in the last 12
months?
3)
“(I/we) couldn’t afford to eat balanced meals.” Was that often, sometimes, or
never true for (you/your household) in the last 12 months?
Adult:
1)
In the last 12 months, since last (name of current month), did (you/you or other
adults in your household) ever cut the size of your meals or skip meals because there
wasn't enough money for food?
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2)
[IF YES ABOVE, ASK] How often did this happen—almost every month, some
months but not every month, or in only 1 or 2 months?
3)
In the last 12 months, did you ever eat less than you felt you should because there
wasn't enough money for food?
4)
In the last 12 months, were you every hungry but didn't eat because there wasn't
enough money for food?
5)
In the last 12 months, did you lose weight because there wasn't enough money for
food?
6)
In the last 12 months, did (you/you or other adults in your household) ever not eat
for a whole day because there wasn't enough money for food?
7)
[IF YES ABOVE, ASK] How often did this happen—almost every month, some
months but not every month, or in only 1 or 2 months?
Child:
1)
“(I/we) relied on only a few kinds of low-cost food to feed (my/our) child/the
children) because (I was/we were) running out of money to buy food.” Was that often,
sometimes, or never true for (you/your household) in the last 12 months?
2)
“(I/We) couldn’t feed (my/our) child/the children) a balanced meal, because
(I/we) couldn’t afford that.” Was that often, sometimes, or never true for (you/your
household) in the last 12 months?
3)
"(My/Our child was/The children were) not eating enough because (I/we) just
couldn't afford enough food." Was that often, sometimes, or never true for (you/your
household) in the last 12 months?
4)
In the last 12 months, since (current month) of last year, did you ever cut the size
of (your child's/any of the children's) meals because there wasn't enough money for food?
5)
In the last 12 months, did (CHILD’S NAME/any of the children) ever skip meals
because there wasn't enough money for food?
6)
[IF YES ABOVE ASK] How often did this happen—almost every month, some
months but not every month, or in only 1 or 2 months?
7)
In the last 12 months, (was your child/were the children) ever hungry but you just
couldn't afford more food?
8)
In the last 12 months, did (your child/any of the children) ever not eat for a whole
day because there wasn't enough money for food?
Both adult and household food security were defined per USDA regulations as fully food
secure, marginal food security, low food security, or very low food security. The household
measure uses all 18 items, or 10 items for households without children, consistent with the CPS
categorical measure. The four categories created for household food security are: food secure,
marginally food secure, food insecure without hunger, and food insecure with hunger. The adult
measure uses 10 items and categories are the same as those used for the household measure. For
adult-only households, the household and adult measures are identical (NHANES 2001-2002,
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2004). For this analysis, the categories correspond to full food security, marginal, low and very
low food security respectively in the attached tables.
The child measure categorization is based upon “Measuring Children’s Food Security in
U.S. Households, 1995-99” (ERS research report) which uses the 8 child-referenced items to
classify households into two categories, no or insufficient evidence of hunger versus clear
evidence of hunger. In order to keep consistent with the household and adult measures,
NHANES data are grouped into four categories. The first category in the ERS report is separated
into three categories 1) food quantity and quality unaffected, 2) marginally food secure, and 3)
food insecure without hunger. The most severe category is scored the same as that in the ERS
report labeled “child food insecure with hunger” (NHANES 2001-2002, 2004). For the 20032006 surveys, this was updated to the categories 1) food quality & quantity unaffected, 2)
reduced food quality or quantity, 3) reduced food quality and quantity, and 4) severely reduced
food quality and quantity (National Health and Nutrition Examination Survey 2003-2004, 2007).
Statistical analysis was conducted with Statistical Package for the Social Sciences (SPSS)
version 26. Descriptive analyses, t-Tests for continuous dependent values and Chi-Square tests
for categorical variables, were conducted to examine the prevalence of study variables by
NAFLD status. Univariate and multivariate logistic regression was conducted to find which
variables predict NAFLD (yes, no) in the pediatric population with a 95% confidence interval. In
keeping with the recent policy from the American Statistical Association, we will report specific
p-values for each test, and not use a threshold cut-point.
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Results
Table 1 describes the demographic and clinicopathological characteristics of our study
population. The study sample (n=4714) consists of males (n=2412) and non-pregnant females
(n=2302) with valid ALT results, n=3921 for normal ALT and n=793 for elevated ALT. The
overall prevalence of NAFLD as defined by elevated ALT >30 U/L was 793/3921 or 20.22%.
Prevalence was similar across sexes with 17.2% of males and 16.5% of females showing
elevated ALT (p=.521). Prevalence was varied across race/ethnicity with Non-Hispanic Whites
(NHW) having a much lower prevalence, 15.0%, than Non-Hispanic Blacks (NHB),18.8%, the
Hispanic population at 16.3% and other races/ethnicities at 17.3% (p=.055). Within the CRP
quartiles high ALT ranges from 16.5% (Q2) to 17.4% (Q4) with no clear pattern (p=.785).
Similarly, with BMI, 16.5% of the underweight, 17.0% of normal weight, 16.4% overweight,
18.3% of obese, and 14.9% of morbidly obese population showed elevated ALT levels (p=.831).
DII results across quartiles were 15.4% (Q1), 17.1% (Q2), 17.5% (Q3), and 16.9% (Q4) for
elevated ALT (p=.576). For child food security, elevated ALT levels were found at 17.1%,
14.7%, 17.4%, and 20.6% for Unaffected, Reduced Quality or Quantity, Reduced Quality and
Quantity, and Severely Reduced Quality and Quantity of FS, respectively (p=.549). Adult and
household FS showed similar elevated ALT values per level of food security. Adult FS had
elevated ALT in 16.5% of the fully food secure, 18.2% in marginally food secure, 16.3% in low
food security, and 18.7% in the very low food security populations (p=.568). Household food
security was the final characteristic analyzed, with 16.4%, 19.1%, 16.6% and 18.1% of the full,
marginal, low, and very low FS populations respectively displaying elevated ALT.
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Table 2 describes the same demographic and clinicopathological characteristics of our study
population as Table 1 but is comparing the populations of those included in the sample (n=4714)
versus those who were excluded (n=2364) such as pregnant females or those with no ALT
values. This was done to ensure there was no selection or sample bias in defining the sample
cohort. Of the total 7078, 4714 samples (66.6%) were included and 2364 (33.3%) were excluded.
Across all the variables that were examined, the included samples were fairly representative in
comparison to the excluded samples, for example, included males were 51.2% of the cohort
compare to 47.8% excluded. The largest discrepancies were in CRP and BMI. For CRP, the
breakdown between the quartiles was 60.7%, 14.1%, 8.8% and 7.7% included versus 51.1%,
12.9%, 9.8%, and 8.8% excluded for Q1 to Q4 respectively. In the BMI categories, the included
sample breakdown was 14.3%, 54.4%, 18.2%, 7.6%, and 5.5% for the underweight to morbidly
obese population respectively. This is compared to the excluded breakdown of 12.6%, 52.2%,
17.5%, 10.5%, and 7.2%. For a majority of the samples the included participants were
representative respective to the excluded cohort, the largest variation being a 9.6% difference in
the Q1 selection sample for CRP.
Table 3 stratifies the study population by race/ethnicity. For sex, Non-Hispanic Black rates of
elevated ALT were 18.7% for males and 18.9% for females (p=.893). In CRP, Non-Hispanic
Black elevated ALT was 19.8%, 14.9%, 16%, and 20% in quartiles 1 to 4, respectively. NonHispanic Black elevated ALT rates for BMI were found to be 18.7% for underweight, 18.9% for
normal weight, 20.7% for overweight, 18.9% for obese, and 13.1% for morbidly obese
populations. Across DII quartiles, Non-Hispanic Black elevated ALT was 18.3%, 20.6%, 16.7%,
and 19.5%. For child food security, prevalence of elevated ALT in the severely reduced quality
and quantity was the highest of all categories within Non-Hispanic Blacks at 22%. Adult food
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security elevated ALT levels for Non-Hispanic Blacks were 18.6%, 20.3%, 17.8% and 21.6% for
full, marginal, low, and very low food security populations. Household food security elevated
ALT levels for Non-Hispanic Blacks were 18.4%, 20.8%, 19.6% and 20.5% for full, marginal,
low, and very low food security populations.
Table 4 presents results of univariate and multivariate models of a binary logistic regression on
all the variables previously examined. Non-Hispanic Black participants were 1.31 times more
likely (95% CI 1.07-1.59) to have elevated ALT compared to Non-Hispanic Whites in the
univariate model and 1.25 times more likely (95% CI 1.00-1.57) in the multivariate model.
Increased DII score as stratified by quartile (i.e., increasingly pro-inflammatory) were linked to
elevated risk of elevated ALT (e.g., Q2vs Q1: OR=1.23, 95% CI .95-1.59; and, Q3 vs Q1,
OR=1.31, 95% CI 1.01-1.69.) Adolescents characterized as having reduced quality or quantity of
food appeared less likely to have elevated ALT compared to children rated as unaffected by
insecurity (OR=0.63, 95% CI 0.37-1.09). Similarly, those characterized on the adult scale as
being marginally insecure were at a possible reduced risk compared to those fully secure
(OR=0.58, 95% CI 0.22-1.51). In contrast, using the household level assessment, adolescents
marginally food insecure were at possible increased risk for elevated ALT compared to the fully
secure (OR=2.08, 95% CI 0.80-5.41).

21

Discussion
Prevalence of NAFLD. The prevalence of elevated ALT in the overall cohort was 20.22%. This
did not vary noticeably for any variable except for race ethnicity. Non-Hispanic Blacks had the
highest elevated ALT of 18.8% in comparison to Non-Hispanic Blacks at 15.0%, Hispanics at
16.3% and other at 17.3% (p=.055). Elevated ALT was indicated as levels higher than 30 U/L
but in the future, this study could be modified to the updated cut-offs of 22 mg/dl for girls and 26
mg/dl based on the clinical practice guideline released in 2017 as this could have an impact on
the prevalence proportions for boys. As different studies use a variety of cut-off levels, 22 and 26
could be reference lab values for evaluating elevated liver enzymes due to medical conditions
like viral hepatitis, autoimmune hepatitis, obstructive liver disease and others. However, these
levels are for clinical evaluation, in this study we are using epidemiological evaluation. Some
epidemiological studies used 40 and got similar results (Vos et al., 2017).
Food Insecurity and NAFLD. Estimated risks associated with Food Security were inconclusive
and are therefore suggestive of inconsistency across the three measures. Among the child and
adult assessments of food security, adolescents in the “reduced quality or quantity” or “marginal”
food security respectively appeared less likely to have elevated ALT compared to those rated as
fully food secure. In contrast, using the household level assessment, adolescents categorized as
marginally food insecure were at possible increased risk for elevated ALT compared to the fully
secure. While all food security analyses were not convincing due to lack of statistical
significance, unravelling contrasting trends might be explained by more sophisticated analyses
examining links among variables, such as factor analysis or structural equation modeling.
Alternatively, it is possible that the impact of insecurity on NAFLD risk is a longer-term risk
factor that might be revealed in prospective studies. This possibility in adolescents is consistent
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with prior studies in adults linking food insecurity to the MetS and obesity, both of which have
been linked to NAFLD. For example, Golovaty et al. reported a relationship between lowincome adults and NAFLD. Golovaty et al. found that the dose-response relation between
severity of food security and NAFLD in adults was comparable to trends with obesity and
diabetes. Further research in the pediatric cohort could be done to investigate a similar doseresponse relationship. An alternate explanation offered by Golovaty et al. was that worsened
health status (NAFLD) causes food insecurity which is another area for future research.
Regardless of the direction of the relationship between food security and NAFLD, further
investigation is needed as these findings could impact potential NAFLD interventions and policy
for low-income and food-insecure households.
Race/Ethnicity and NAFLD. Non-Hispanic Black adolescents had a 25% increased likelihood
of elevated ALT risk compared to Non-Hispanic whites. This effect is supported by the
observation that Non-Hispanic Blacks had the highest prevalence of overweight/obesity (20.7%).
We observed no increased risk in Hispanics compared to White adolescents which is inconsistent
with prior research in race among adults. Our null finding for the pediatric population is novel,
and further clarifying research is suggested to determine if risks for children and adults differ.
Metabolic Factors and NAFLD. While CRP and BMI, have been known as metabolic
indicators of diabetes and obesity, there were no significant findings when compared to elevated
ALT for prevalence. Increased DII score, however, was linked to elevated risk of elevated ALT,
which might find indirect support in a 2019 study found that change in diet improved intestinal
permeability in patients with NAFLD and patients with lower diet adherence had higher values
of DII (Biolato et al., 2019).
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Strengths and Limitations. This study was conducted on a large validated sample which is
nationally representative but there were several limitations. Per the data presented in Table 2, the
sample selection was representative when compared to those excluded so there is minimal bias.
As this was a cross-sectional study, we cannot point to data significance as causation, only
correlation. Since food insecurity is a novel variable in association with NAFLD, this leaves
room for further, more discrete investigation. Further limitations were lack of data for every
variable investigated due to the age range limitations. This is justified as there is a large need for
specific inquiry into pediatric NAFLD versus adult NAFLD. Also, the cut-offs for ALT were
much higher than the current recommended ranges as a previous studies cut-off was utilized to
be better able to compare the findings. Since the data sampled was 2001-2006, this could be
recreated with more recent data with the most up-to-date ALT cut-offs.
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Conclusion
In a cross-sectional study of US adolescents (12-19), we found that NAFLD prevalence
was increased somewhat in Non-Hispanic Blacks (18.8%) in comparison to Non-Hispanic
Whites (15.0%), which was supported by an observation of a 25% increased risk for elevated
ALT in multivariate logistic regression. A pro-inflammatory diet appears to be a risk factor for
elevated ALT in adolescents. With the inconsistency in linking NAFLD with food insecurity, we
posit that this early risk factor might contribute to adult onset of this disease. Future studies are
suggested to identify underlying factors linked to race that would pre-dispose adolescent onset of
NAFLD. Further, we suggest that retrospective cohort analyses of early-life food insecurity
might reveal a connection to adult onset NAFLD. In general, more work is required to
understanding the causes of adolescent onset NAFLD so that public health interventions and
policies can be developed to stem this emerging epidemic.
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Table 1 Demographics and Clinicopathological Factors of participants age 12-19 by ALT status in
NHANES 2001-06 (n=4714)
Normal
n=3921

High
n=793

Sex
Male (n= 2412)
Female (n=2302)

1998 (82.8%)
1923 (83.5%)

414 (17.2%)
379 (16.5%)

.521

Race/Ethnicity
Non-Hispanic White (n=1329)
Non-Hispanic Black (n=1571)
Hispanic (n=1629)
Other (n=185)

1129 (85.0%)
1276 (81.2%)
1363 (83.7%)
153 (82.7%)

200 (15.0%)
295 (18.8%)
266 (16.3%)
32 (17.3%)

.055

CRP1 (n=4304)
Q1 [<.09]
Q2 [.09-.23]
Q3 [.23-.52]
Q4 [>.52]

2370 (82.9%)
556 (83.5%)
346 (83.2%)
299 (82.6%)

490 (17.1%)
110 (16.5%)
70 (16.8%)
63 (17.4%)

.785

BMI2 (n=4620)
Underweight [<18.5]
Normal [18.5-24.9]
Overweight [25.0-29.9]
Obese [30.0-34.9]
Morbidly Obese [>35.0]

552 (83.5%)
2086 (83.0%)
703 (83.6%)
285 (81.7%)
217 (85.1%)

109 (16.5%)
428 (17.0%)
138 (16.4%)
64 (18.3%)
38 (14.9%)

.831

DII3 (n=4504)
Q1 [< -.82]
Q2 [-.82-.32]
Q3 [.32-1.25]
Q4 [>1.25]

854 (84.6%)
958 (82.9%)
937 (82.5%)
1000 (83.1%)

155 (15.4%)
197 (17.1%)
199 (17.5%)
204 (16.9%)

.576

Food Security4 – Child (n=4022)
Unaffected
Reduced Quality or Quantity
Reduced Quality and Quantity
Severely Reduced Quality and Quantity

2484 (82.9%)
255 (85.3%)
517 (82.6%)
81 (79.4%)

511 (17.1%)
44 (14.7%)
109 (17.4%)
21 (20.6%)

.549

Food Security4 – Adult (n=4495)
Full
Marginal
Low
Very Low

2479 (83.5%)
481 (81.8%)
462 (83.7%)
314 (81.3%)

490 (16.5%)
107 (18.2%)
90 (16.3%)
72 (18.7%)

.568

Food Security4 – Household (n=4495)
Full
Marginal
Low
Very Low

2449 (83.6%)
382 (80.9%)
579 (83.4%)
326 (81.9%)

482 (16.4%)
90 (19.1%)
115 (16.6%)
72 (18.1%)

1
2
3
4

p-value

.481

C-reactive protein (CRP) is an inflammatory marker and has been linked to CVD and obesity (Barinas-Mitchell et al., 2001)
Body-mass Index (BMI) was categorized per CDC guidelines
Dietary inflammatory Index (DII) is based on 8 pro-inflammatory and 8 anti-inflammatory components to assess the inflammatory
potential of dietary factors to provide a quantitative means for assessing the role of diet in relation to health outcomes (Kanauchi et al.,
2019)
Food security was assessed using the US Food Security Survey Module (US FSSM). For further specifications see Methods (p. 15)
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Table 2 Comparison of Included (n=4714) versus Excluded (n=2364) Participants age 12-19
NHANES 2001-06 (n=7078)
Included
n=4714

Excluded
n=2364

Sex
Male (n= 2412)
Female (n=2302)

2412 (51.2%)
2302 (48.8%)

1129 (47.8%)
1235 (52.2%)

.007

Race/Ethnicity
Non-Hispanic White
Non-Hispanic Black
Hispanic
Other

1329 (28.2%)
1571 (33.3%)
1629 (34.6%)
185 (3.9%)

615 (26.0%)
794 (33.6%)
847 (35.8%)
108 (4.6%)

.168

CRP1 (n=4304)
Q1 [<.09]
Q2 [.09-.23]
Q3 [.23-.52]
Q4 [>.52]

2860 (60.7%)
666 (14.1%)
416 (8.8%)
362 (7.7%)

1209 (51.1%)
306 (12.9%)
231 (9.8%)
207 (8.8%)

.000

BMI2 (n=4620)
Underweight [<18.5]
Normal [18.5-24.9]
Overweight [25.0-29.9]
Obese [30.0-34.9]
Morbidly Obese [>35.0]

661 (14.3%)
2514 (54.4%)
841 (18.2%)
349 (7.6%)
255 (5.5%)

269 (12.6%)
1111 (52.2%)
372 (17.5%)
223 (10.5%)
154 (7.2%)

.000

DII3 (n=4504)
Q1 [< -.82]
Q2 [-.82-.32]
Q3 [.32-1.25]
Q4 [>1.25]

1009 (22.4%)
1155 (25.6%)
1136 (25.2%)
1204 (26.7%)

467 (22.6%)
526 (25.4%)
526 (25.4%)
551 (26.6%)

.995

Food Security4 – Child (n=4022)
Unaffected
Reduced Quality or Quantity
Reduced Quality and Quantity
Severely Reduced Quality and Quantity

2995 (74.5%)
299 (7.4%)
626 (15.6%)
102 (2.5%)

1524 (75.9%)
140 (7.0%)
294 (14.6%)
49 (2.4%)

Food Security4 – Adult (n=4495)
Full
Marginal
Low
Very Low

2969 (66.1%)
588 (13.1%)
552 (12.3%)
386 (8.6%)

1525 (66.7%)
283 (12.4%)
325 (14.2%)
152 (6.7%)

Food Security4 – Household (n=4495)
Full
Marginal
Low
Very Low

2931 (65.2%)
472 (10.5%)
694 (15.4%)
398 (8.9%)

1502 (65.7%)
240 (10.5%)
363 (15.9%)
180 (7.9%)

1
2
3
4

p-value

.670

.007

.582

C-reactive protein (CRP) is an inflammatory marker and has been linked to CVD and obesity (Barinas-Mitchell et al., 2001)
Body-mass Index (BMI) was categorized per CDC guidelines
Dietary inflammatory Index (DII) is based on 8 pro-inflammatory and 8 anti-inflammatory components to assess the inflammatory
potential of dietary factors to provide a quantitative means for assessing the role of diet in relation to health outcomes (Kanauchi et al.,
2019).
Food security was assessed using the US Food Security Survey Module (US FSSM). For further specifications see Methods (p. 15)
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Table 3 Demographics and Clinicopathological Factors of participants age 12-19 by ALT status in NHANES 2001-06 (n=4714)
Split by Race/Ethnicity
Non-Hispanic White
(n=1329)
Normal
n=3921

High
n=793

564
(84.3%)
565
(85.6%)
710
(84.9%)
156
(83.4%)
94
(83.9%)
64
(88.9%)

105
(15.7%)
95
(14.4%)
126
(15.1%)
31
(16.6%)
18
(16.1%)
8
(11.1%)

Normal
n=3921

High
n=793

676
(81.3%)
600
(81.1%)
792
(80.2%)
160
(85.1%)
110
(84%)
104
(80%)

155
(18.7%)
140
(18.9%)
195
(19.8%)
28
(14.9%)
21
(16%)
26
(20%)

Underweight
[<18.5]

180
(82.9%)

37
(17.1%)

165
(81.3%)

Normal
[18.5-24.9]

613
(84.7%)

111
(15.3%)

Overweight
[25.0-29.9]

188
(87%)

28
(13%)

Obese [30.034.9]
Morbidly
Obese
[>35.0]

88
(82.2%)
39
(90.7%)

Variable

Sex

Male (n=
2412)
Female
(n=2302)
Q1 [<.09]

CRP1
(n=4304)

Q2 [.09-.23]
Q3 [.23-.52]
Q4 [>.52]

BMI2
(n=4620)

Non-Hispanic Black
(n=1571)

Hispanic (n=1629)
Normal
n=3921

High
n=793

670
(82.6%)
693
(84.7%)
775
(83.8%)
216
(82.4%)
130
(82.3%)
125
(82.2%)

141
(17.4%)
125
(15.3%)
150
(16.2%)
46
(17.6%)
28
(17.7%)
27
(17.8%)

38
(18.7%)

182
(85%)

687
(81.1%)

160
(18.9%)

203
(79.3%)

53
(20.7%)

19
(17.8%)

86
(81.1%)

4
(9.3%)

106
(86.9%)

P-value

0.507

0.84

0.537

Other (n=185)
Normal
n=3921

High
n=793

88
(87.1%)
65
(77.4%)
93
(83%)
24
(82.8%)
12
(80%)

13
(12.9%)
19
(22.6%)
19
(17%)
5
(17.2%)

6 (75%)

2 (25%)

32
(15%)

25
(92.6%)

2
(7.4%)

705
(83.8%)

136
(16.2%)

81
(79.4%)

21
(20.6%)

285
(84.6%)

52
(15.4%)

27
(84.4%)

5
(15.6%)

20
(18.9%)

97
(80.8%)

23
(19.2%)

14
(87.5%)

2
(12.5%)

16
(13.1%)

68
(80%)

17
(20%)

4 (80%)

1 (20%)

28

P-value

0.893

0.515

0.525

P-value

0.251

0.536

0.725

P-value

0.081

0.968

3 (20%)

0.559

Non-Hispanic White
(n=1329)
Variable

DII3
(n=4504)

Q1 [< .82]
Q2 [-.82.32]
Q3 [.321.25]
Q4 [>1.25]
Unaffected

Food
Security4
– Child
(n=4022)

Reduced
Quality or
Quantity
Reduced
Quality
and
Quantity
Severely
Reduced
Quality
and
Quantity
Full

Food
Security4
– Adult
(n=4495)

Marginal
Low
Very Low

Normal
n=3921

High
n=793

270
(85.2%)
263
(84.8%)
275
(85.4%)
284
(84.3%)
821
(84.1%)

47
(14.8%)
47
(15.2%)
47
(14.6%)
53
(15.7%)
155
(15.9%)

36
(92.3%)

3
(7.7%)

62
(84.9%)

11
(15.1%)

9
(81.8%)
887
(84.5%)
70
(88.6%)
54
(84.4%)
63
(88.7%)

Non-Hispanic Black
(n=1571)
Normal
n=3921

High
n=793

254
(81.7%)
278
(79.4%)
319
(83.3%)
368
(80.5%)
741
(80.8%)

57
(18.3%)
72
(20.6%)
64
(16.7%)
89
(19.5%)
176
(19.2%)

107
(81.7%)

24
(18.3%)

187
(78.9%)

50
(21.1%)

2
(18.2%)

39
(78%)

163
(15.5%)
9
(11.4%)
10
(15.6%)
8
(11.3%)

735
(81.4%)
184
(79.7%)
148
(82.2%)
134
(78.4%)

P-value

0.98

0.576

0.61

Hispanic (n=1629)
Normal
n=3921

High
n=793

298
(87.1%)
380
(84.3%)
305
(79.2%)
305
(85%)
820
(83.9%)

44
(12.9%)
71
(15.7%)
80
(20.8%)
54
(15%)
157
(16.1%)

98
(85.2%)

17
(14.8%)

256
(84.8%)

46
(15.2%)

11
(22%)

31
(79.5%)

168
(18.6%)
47
(20.3%)
32
(17.8%)
37
(21.6%)

741
(84.9%)
216
(81.2%)
249
(84.1%)
106
(80.9%)

29

P-value

0.573

0.861

0.732

Other (n=185)
Normal
n=3921

High
n=793

32
(82.1%)
37
(84.1%)
38
(82.6%)
43
(84.3%)
102
(81.6%)

7
(17.9%)
7
(15.9%)
8
(17.4%)
8
(15.7%)
23
(18.4%)

14
(100%)

0 (0%)

12
(85.7%)

2
(14.3%)

8
(20.5%)

2
(100%)

0 (0%)

132
(15.1%)
50
(18.8%)
47
(15.9%)
25
(19.1%)

116
(81.1%)
11
(91.7%)
11
(91.7%)
11
(84.6%)

27
(18.9%)
1
(8.3%)
1
(8.3%)
2
(15.4%)

P-value

0.027

0.838

0.408

P-value

0.99

0.309

0.651

Non-Hispanic White
(n=1329)
Variable
Full
Food
Security4 –
Household
(n=4495)

Marginal
Low
Very
Low

1
2
3
4

Normal
n=3921

High
n=793

884
(84.4%)
61
(88.4%)
69
(86.3%)
60
(88.2%)

163
(15.6%)
8
(11.6%)
11
(13.8%)
8
(11.8%)

Non-Hispanic Black
(n=1571)

P-value

Normal
n=3921

High
n=793

0.672

719
(81.6%)
145
(79.2%)
197
(80.4%)
140
(79.5%)

162
(18.4%)
38
(20.8%)
48
(19.6%)
36
(20.5%)

Hispanic (n=1629)

P-value

Normal
n=3921

High
n=793

0.834

733
(84.9%)
165
(79.3%)
298
(84.4%)
116
(81.7%)

130
(15.1%)
43
(20.7%)
55
(15.6%)
26
(18.3%)

Other (n=185)

P-value

Normal
n=3921

High
n=793

P-value

0.217

113
(80.7%)
11
(91.7%)
15
(93.8%)
10
(83.3%)

27
(19.3%)
1
(8.3%)
1
(6.3%)
2
(16.7%)

0.487

C-reactive protein (CRP) is an inflammatory marker and has been linked to CVD and obesity (Barinas-Mitchell et al., 2001)
Body-mass Index (BMI) was categorized per CDC guidelines
Dietary inflammatory Index (DII) is based on 8 pro-inflammatory and 8 anti-inflammatory components to assess the inflammatory potential of dietary factors to provide a quantitative means
for assessing the role of diet in relation to health outcomes (Kanauchi et al., 2019).
Food security was assessed using the US Food Security Survey Module (US FSSM). For further specifications see Methods (p. 15)
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Table 4 Predictors of ALT Status in Participants age 12-19 in NHANES 2001-06 (n=4714)
Univariate Model
OR (95% CI)

Multivariate Model
OR (95% CI)

Sex
Male (ref)
Female

1.00
.951 (.816-1.11)

1.00
.98 (.82-1.17)

Race/Ethnicity
NHW (ref)
NHB
Hispanic
Other

1.00
1.31 (1.07-1.59)
1.10 (0.92-1.35)
1.18 (0.78-1.78)

1.00
1.25 (1.00-1.57)
.99 (.79-1.25)
.98 (.61-1.58)

CRP1 (n=4304)
Q1 [<.09]
Q2 [.09-.23]
Q3 [.23-.52]
Q4 [>.52]

1.00
.96 (.76-1.20)
.98 (.74-1.23)
1.02 (.76-1.36)

1.00
.94 (.72-1.22)
.87 (.63-1.22)
1.13 (.80-1.59)

BMI2 (n=4620)
Underweight [<18.5]
Normal [18.5-24.9]
Overweight [25.0-29.9]
Obese [30.0-34.9]
Morbidly Obese [>35.0]

1.00
1.04 (.83-1.31)
.99 (.76-1.31)
1.14 (.81-1.60)
.89 (.59-1.33)

1.00
1.04 (.81-1.33)
1.11 (.82-1.50)
1.12 (.75-1.66)
1.04 (.66-1.63)

DII3 (n=4504)
Q1 [< -.82]
Q2 [-.82-.32]
Q3 [.32-1.25]
Q4 [>1.25]

1.00
1.13 (.90-1.43)
1.17(.93-1.47)
1.12 (.89-1.41)

1.00
1.23 (.95-1.59)
1.31 (1.01-1.69)
1.14 (.88-1.48)

Food Security4 – Child (n=4022)
Unaffected
Reduced Quality or Quantity
Reduced Quality and Quantity
Severely Reduced Quality and Quantity

1.00
.84 (.60-1.17)
1.03 (.82-1.29)
1.26 (.77-2.06)

1.00
.63 (.37-1.09)
.89 (.51-1.54)
1.04 (.47-2.29)

Food Security4 – Adult (n=4495)
Full
Marginal
Low
Very Low

1.00
1.13 (.89-1.42)
.99 (.77-1.26)
1.16 (.88-1.53)

1.00
.58 (.22-1.51)
.54 (.17-1.68)
1.11 (.27-4.55)

Food Security4 – Household (n=4495)
Full
Marginal
Low
Very Low

1.00
1.19 (.93-1.54)
1.01 (.81-1.26)
1.12 (.85-1.48)

1.00
2.08 (.80-5.41)
2.03 (.53-7.75)
1.26 (.23-6.75)

1
2
3
4

C-reactive protein (CRP) is an inflammatory marker and has been linked to CVD and obesity (Barinas-Mitchell et al., 2001)
Body-mass Index (BMI) was categorized per CDC guidelines
Dietary inflammatory Index (DII) is based on 8 pro-inflammatory and 8 anti-inflammatory components to assess the inflammatory
potential of dietary factors to provide a quantitative means for assessing the role of diet in relation to health outcomes (Kanauchi et al.,
2019).
Food security was assessed using the US Food Security Survey Module (US FSSM). For further specifications see Methods (p. 15)
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